On Friday, the FDA expanded its approved use of Afrezza for kids six years and older
On Friday, the FDA expanded its approved use of Afrezza for kids six years and older who have Type 1 diabetes or those who require insulin with Type 2 diabetes — making it the first ever needle-free insulin option for pediatric patients, according to MannKind Corporation, the maker of Afrezza.
ABC News
ABC News is your daily source for breaking national and world news, exclusive interviews and 24/7 live streaming coverage that will help you stay up to date on the events shaping our world. https://abcnews.go.com...